Eccogene Announces First Patient Enrolled in MOSAIC Phase 2a Trial Evaluating ECC4703 and ECC0509, Individually and in Combination, for the Treatment of MASH [Yahoo! Finance]
Worker dies at underground potash mine in southern Saskatchewan [Yahoo! Finance Canada]
Mosaic (MOS) Climbs 4% on Bargain-Hunting [Yahoo! Finance]
Mosaic (MOS) Gets Price Target Cut as RBC Assesses 2026 Fertilizer Trends [Yahoo! Finance]
Mosaic (NYSE:MOS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.